| 11.75 Data as of May 16 |  0.00 / 0.00%Today’s Change | 10.93 Today|||52-Week Range 13.14 | -10.31% Year-to-Date |
| Previous close | 11.75 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 7 |
| Market cap | $343.2M |
| Dividend yield | 2.62% |
| Earnings growth (last year) | +40.18% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | +8.55% |
| P/E ratio | -- |
| Price/Sales | 1.37 |
| Price/Book | 2.33 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $225.7M |
| Annual profit (last year) | $22.7M |
| Net profit margin | 10.04% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Executive Director Jonathan M. Glenn |
Executive Director & Group Finance Director Richard John Cotton |
Corporate headquarters Hemel Hempstead, Hertfordshire |
.
